Skip to main content
. 2022 Sep 16;12(9):135. doi: 10.1038/s41408-022-00730-5

Table 4.

Treatment received at diagnosis and at first relapse in the overall series and by periods of time.

Plasmacytomas Overall Period 1 Period 2
At diagnosis N = 1304 N = 577 N = 727
QT 873 (66.9%) 565 (97.9%) 308 (42.3%)
PI 180 (13.8%) 180 (24.7%)
IMiD 70 (5.3%) 70 (9.6%)
PI + IMiD 150 (11.5%) 150 (20.6%)
MAb 16 (1.2%) 16 (2.1%)
ASCT 413 (31.6%) 77 (13.3%) 336 (46.2%)
Relapsed patients* N = 768 N = 305 N = 463
QT 386 (50.2%) 271 (88.8%) 124 (26.7%)
PI 155 (20.9%) 7 (2.2%) 154 (33.2%)
IMiD 110 (14.3%) 18 (5.9%) 92 (19.8%)
PI + IMiD 55 (7.1%) 55 (11.8%)
MAb 25 (3.2%) 25 (5.3%)

*Relapsed patients who received salvage therapy.